Prescription Drug Price Reporting Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5239: Prescription Drug Price Reporting Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5239/
"H.R. 5239: Prescription Drug Price Reporting Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5239/.
H.R. 5239, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5239/.
[H.R. 5239: Prescription Drug Price Reporting Act](https://openamerica.io/bill/116-HR-5239/)